HK1002853A1 - A combination of a 5-ht uptake inhibitor with a selective 5-ht1a antagonist - Google Patents

A combination of a 5-ht uptake inhibitor with a selective 5-ht1a antagonist

Info

Publication number
HK1002853A1
HK1002853A1 HK98101990A HK98101990A HK1002853A1 HK 1002853 A1 HK1002853 A1 HK 1002853A1 HK 98101990 A HK98101990 A HK 98101990A HK 98101990 A HK98101990 A HK 98101990A HK 1002853 A1 HK1002853 A1 HK 1002853A1
Authority
HK
Hong Kong
Prior art keywords
selective
combination
uptake inhibitor
ht1a antagonist
ht1a
Prior art date
Application number
HK98101990A
Other languages
English (en)
Inventor
John Evenden
Seth-Olov Thorberg
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HK1002853A1 publication Critical patent/HK1002853A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK98101990A 1995-04-27 1998-03-10 A combination of a 5-ht uptake inhibitor with a selective 5-ht1a antagonist HK1002853A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9501567A SE9501567D0 (sv) 1995-04-27 1995-04-27 A new combination
PCT/SE1996/000526 WO1996033710A1 (en) 1995-04-27 1996-04-23 A combination of a 5-ht uptake inhibitor with a selective 5-ht1a antagonist

Publications (1)

Publication Number Publication Date
HK1002853A1 true HK1002853A1 (en) 1998-09-25

Family

ID=20398119

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98101990A HK1002853A1 (en) 1995-04-27 1998-03-10 A combination of a 5-ht uptake inhibitor with a selective 5-ht1a antagonist

Country Status (30)

Country Link
US (5) US5962514A (hu)
EP (1) EP0822813B1 (hu)
JP (1) JPH11504037A (hu)
KR (1) KR100419810B1 (hu)
CN (1) CN1102386C (hu)
AR (1) AR002990A1 (hu)
AT (1) ATE216579T1 (hu)
BR (1) BR9608252A (hu)
CA (1) CA2218181A1 (hu)
CZ (1) CZ335697A3 (hu)
DE (1) DE69620878T2 (hu)
DK (1) DK0822813T3 (hu)
EE (1) EE03553B1 (hu)
ES (1) ES2175089T3 (hu)
HK (1) HK1002853A1 (hu)
HU (1) HUP9801946A3 (hu)
IL (1) IL117988A0 (hu)
IS (1) IS1821B (hu)
NO (1) NO317057B1 (hu)
NZ (1) NZ306602A (hu)
PL (1) PL183997B1 (hu)
PT (1) PT822813E (hu)
RU (1) RU2183955C2 (hu)
SE (1) SE9501567D0 (hu)
SK (1) SK282060B6 (hu)
TR (1) TR199701254T1 (hu)
TW (1) TW458777B (hu)
WO (1) WO1996033710A1 (hu)
YU (1) YU25696A (hu)
ZA (1) ZA962982B (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination
SE9703374D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination
WO1999061014A2 (en) * 1998-05-28 1999-12-02 Sepracor Inc. Compositions and methods employing r(-) fluoxetine and other active ingredients
SE9803156D0 (sv) * 1998-09-16 1998-09-16 Astra Ab A new composition
SE9803157D0 (sv) * 1998-09-16 1998-09-16 Astra Ab A new composition
SE9803158D0 (sv) * 1998-09-16 1998-09-16 Astra Ab A new composition
SE9803155D0 (sv) * 1998-09-16 1998-09-16 Astra Ab A new composition
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
UA77650C2 (en) * 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
US6331233B1 (en) 2000-02-02 2001-12-18 Honeywell International Inc. Tantalum sputtering target with fine grains and uniform texture and method of manufacture
AU9543601A (en) 2000-10-13 2002-04-22 Neurosearch As Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
US20030166554A1 (en) * 2001-01-16 2003-09-04 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
US20030185754A1 (en) * 2001-01-16 2003-10-02 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
PL367480A1 (en) * 2001-05-01 2005-02-21 H.Lundbeck A/S The use of enantiomeric pure escitalopram
US7034059B2 (en) 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
US6855735B2 (en) 2002-03-20 2005-02-15 Temple University Of The Commonwealth System Of Higher Education Ketamine treatment of restless legs syndrome
AU2003256430A1 (en) * 2002-08-15 2004-03-03 Wyeth AGONISM OF THE 5HT2a RECEPTOR FOR TREATMENT OF THERMOREGULATORY DYSFUNCTION
US20050032873A1 (en) * 2003-07-30 2005-02-10 Wyeth 3-Amino chroman and 2-amino tetralin derivatives
US7695601B2 (en) * 2006-05-09 2010-04-13 The United States Of America As Represented By The Secretary Of The Army Electrochemical test apparatus and method for its use
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US20160154928A1 (en) * 2013-07-12 2016-06-02 Immuneering Corporation Systems, methods, and environment for automated review of genomic data to identify downregulated and/or upregulated gene expression indicative of a disease or condition
JP7153653B2 (ja) 2017-02-14 2022-10-14 リサーチ トライアングル インスティテュート プロリン系神経ペプチドｆｆ受容体モジュレーター

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698342A (en) * 1985-07-16 1987-10-06 Serotonin Industries Of Charleston Method and compositions for controlling pain, depression and sedation
US5616610A (en) * 1989-12-22 1997-04-01 Astra Aktiebolag (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination

Also Published As

Publication number Publication date
CA2218181A1 (en) 1996-10-31
IS1821B (is) 2002-08-27
DE69620878D1 (de) 2002-05-29
IS4585A (is) 1997-10-09
US5962514A (en) 1999-10-05
KR19990008068A (ko) 1999-01-25
ZA962982B (en) 1996-10-28
US6172105B1 (en) 2001-01-09
CN1102386C (zh) 2003-03-05
CZ335697A3 (cs) 1998-06-17
NO317057B1 (no) 2004-08-02
BR9608252A (pt) 1999-05-04
ATE216579T1 (de) 2002-05-15
ES2175089T3 (es) 2002-11-16
SK282060B6 (sk) 2001-10-08
EE9700245A (et) 1998-04-15
RU2183955C2 (ru) 2002-06-27
TR199701254T1 (xx) 1998-02-21
IL117988A0 (en) 1996-08-04
AR002990A1 (es) 1998-05-27
EP0822813B1 (en) 2002-04-24
DK0822813T3 (da) 2002-07-29
DE69620878T2 (de) 2002-11-14
SK142997A3 (en) 1998-12-02
EP0822813A1 (en) 1998-02-11
CN1187768A (zh) 1998-07-15
EE03553B1 (et) 2001-12-17
HUP9801946A2 (hu) 2000-05-28
US6184219B1 (en) 2001-02-06
PL183997B1 (pl) 2002-08-30
AU5520296A (en) 1996-11-18
NZ306602A (en) 1999-04-29
NO974921D0 (no) 1997-10-24
AU696356B2 (en) 1998-09-10
NO974921L (no) 1997-12-18
TW458777B (en) 2001-10-11
KR100419810B1 (ko) 2004-04-21
PT822813E (pt) 2002-10-31
US6184218B1 (en) 2001-02-06
US6169098B1 (en) 2001-01-02
SE9501567D0 (sv) 1995-04-27
PL323083A1 (en) 1998-03-02
YU25696A (sh) 1999-06-15
JPH11504037A (ja) 1999-04-06
HUP9801946A3 (en) 2000-12-28
WO1996033710A1 (en) 1996-10-31

Similar Documents

Publication Publication Date Title
HK1002853A1 (en) A combination of a 5-ht uptake inhibitor with a selective 5-ht1a antagonist
PL317368A1 (en) Combination drilling tool
ZA959632B (en) Corrosion inhibitor
IL123268A0 (en) PEP inhibitor
GB9522651D0 (en) Drill chuck
PL331244A1 (en) Polymerisation inhibitor
SG73971A1 (en) Boring tool
HU9603406D0 (en) Reswitching inhibitor
SI0822813T1 (en) A combination of a 5-ht uptake inhibitor with a selective 5-ht 1a antagonist
IL134774A0 (en) A COMBINATION OF A SELECTIVE 5-HT1A ANTAGONIST AND A SELECTIVE h5-HT1B ANTAGONIST OR PARTIAL AGONIST
EP0979651A4 (en) HIGH BLOOD PRESSURE INHIBITOR
GR3033073T3 (en) Drill bit
PL312337A1 (en) Drilling bit
GB9614688D0 (en) Offshore operations vessel
SG49610A1 (en) Novel inhibitor
EP0865336A4 (en) UNDERCUT DRILL
GB9624641D0 (en) Drill bit
GB2284029B (en) Drill pipe
GB2299961B (en) Metal cutting drill
GB2301788B (en) Drill bit
GB9508603D0 (en) Offshore drilling
PL316896A1 (en) Form work anchor
GB9619055D0 (en) Corrosion inhibitor
GB9524472D0 (en) Plumbing tool
SI1021183T1 (en) A COMBINATION OF A SELECTIVE 5-HT1A ANTAGONIST AND A SELECTIVE h5-HT1B ANTAGONIST OR PARTIAL AGONIST

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060423